Clinical Trial Update: GSK2018682 FTIH in Healthy Volunteers [Phase 1]

View source ↗

Summary

GlaxoSmithKline reports the completion of a Phase 1 study of GSK2018682 FTIH in healthy volunteers, with Multiple sclerosis listed as the studied condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• GSK2018682 FTIH

Snippet

Sponsor: GlaxoSmithKline | Conditions: Multiple Sclerosis | Phase 1 | Status: COMPLETED